Elitek
Generic: rasburicase
- Manufacturer
- Sanofi
- NDC
- 0024-5150
- RxCUI
- 1790344
- ICD-10 indication
- E88.3
Affordability Check
How much will you actually pay for Elitek?
In 30 seconds, see every legitimate way to afford Elitek — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Elitek
What is this medication?
Elitek, which is known generically as rasburicase, is a prescription intravenous medication used to manage high levels of uric acid in patients receiving treatment for certain types of cancer, such as leukemia, lymphoma, and solid tumor malignancies. During chemotherapy, cancer cells are destroyed rapidly and release their contents into the bloodstream, a condition known as tumor lysis syndrome. If left unmanaged, the resulting spike in uric acid can lead to severe kidney damage or renal failure.
This medication works as a recombinant urate-oxidase enzyme that aids the body in processing uric acid more efficiently. It functions by converting uric acid into a substance called allantoin, which is much more water-soluble and can be easily excreted by the kidneys through urine. By facilitating this conversion, Elitek helps prevent the accumulation of uric acid crystals in the renal system, thereby protecting kidney function in both pediatric and adult patients undergoing intensive anti-cancer therapy.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for rasburicase.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Elitek →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for rasburicase →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Xospata
Treats same condition · gilteritinib
Mercaptopurine
Treats same condition · Mercaptopurine
Xalkori
Treats same condition · CRIZOTINIB
Elliotts B
Treats same condition · sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
Mitoxantrone
Treats same condition · Mitoxantrone
ADCETRIS
Treats same condition · brentuximab vedotin
ZYNLONTA
Treats same condition · loncastuximab tesirine
Isoniazid
Treats same condition · Isoniazid
Vinblastine Sulfate
Treats same condition · VINBLASTINE SULFATE
Bendamustine
Treats same condition · BENDAMUSTINE HYDROCHLORIDE
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
Elitek treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.